IL-13 Protects against SARS-CoV-2?
Am J Respir Cell Mol Biol
.
2022 Apr;66(4):351-352.
doi: 10.1165/rcmb.2021-0562ED.
Author
R Stokes Peebles Jr
1
2
Affiliations
1
Department of Medicine Vanderbilt University School of Medicine Nashville, Tennessee.
2
The U.S. Department of Veterans Affairs Tennessee Valley Healthcare System Nashville, Tennessee.
PMID:
35085479
PMCID:
PMC8990114
DOI:
10.1165/rcmb.2021-0562ED
No abstract available
Publication types
Editorial
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Comment
MeSH terms
Asthma*
COVID-19*
Humans
Interleukin-13
SARS-CoV-2
Substances
Interleukin-13
Grants and funding
R21 AI145397/AI/NIAID NIH HHS/United States
R01 AI124456/AI/NIAID NIH HHS/United States
R01 AI111820/AI/NIAID NIH HHS/United States
U19 AI095227/AI/NIAID NIH HHS/United States
R01 AI145265/AI/NIAID NIH HHS/United States
I01 BX004299/BX/BLRD VA/United States